These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 7545633

  • 41. Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
    Mutch DG, Powell CB, Kao MS, Collins JL.
    Cancer Res; 1992 Feb 15; 52(4):866-72. PubMed ID: 1737348
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Increased cell-mediated lysis of chicken erythrocytes following the addition of metabolic inhibitors.
    Moody CE, Tunticharoen M, Laux DC.
    Immunology; 1977 Sep 15; 33(3):285-93. PubMed ID: 409663
    [Abstract] [Full Text] [Related]

  • 45. Cytolysis of actinomycin D-treated target cells by cell-free supernatants from human monocytes.
    McKinnon KP, Chen AR, Argov S, Lane BC, Koren HS.
    Immunobiology; 1986 Mar 15; 171(1-2):27-44. PubMed ID: 3710517
    [Abstract] [Full Text] [Related]

  • 46. Cytolytic processes induced by TNF in L929 and K562 differ in DNA fragmentation mechanisms.
    Mirkina II, Mernenko OA, Satpaev DK, Karelin AA, Blishchenko EYu.
    Immunol Lett; 1996 Sep 15; 52(2-3):105-8. PubMed ID: 8905404
    [Abstract] [Full Text] [Related]

  • 47. Tumor necrosis factor-alpha increases ATP content in metabolically inhibited L929 cells preceding cell death.
    Sánchez-Alcázar JA, Ruíz-Cabello J, Hernández-Muñoz I, Pobre PS, de la Torre P, Siles-Rivas E, García I, Kaplan O, Muñoz-Yagüe MT, Solís-Herruzo JA.
    J Biol Chem; 1997 Nov 28; 272(48):30167-77. PubMed ID: 9374498
    [Abstract] [Full Text] [Related]

  • 48. Interferon alfa activates a lytic mechanism in ovarian and cervical carcinoma cells.
    Powell CB, Horuchi T, Kao MS, Collins JL.
    Am J Obstet Gynecol; 1993 Sep 28; 169(3):661-7. PubMed ID: 8372877
    [Abstract] [Full Text] [Related]

  • 49. Divergent effects of taxol on tumor necrosis factor-alpha-mediated cytolysis of ovarian carcinoma cells.
    Williams S, Mutch DG, Xu L, Collins JL.
    Am J Obstet Gynecol; 1992 Dec 28; 167(6):1870-6. PubMed ID: 1361719
    [Abstract] [Full Text] [Related]

  • 50. Sensitization of tumor target cells to cytolysis by murine macrophage cytolytic factor by drugs inhibiting DNA, RNA, and protein synthesis.
    Souchek JM, Leroux ME, Klostergaard J.
    J Leukoc Biol; 1986 Dec 28; 40(6):755-68. PubMed ID: 3465837
    [Abstract] [Full Text] [Related]

  • 51. Measurement of tumor necrosis factor alpha and beta.
    Hogan MM, Vogel SN.
    Curr Protoc Immunol; 2001 May 28; Chapter 6():Unit 6.10. PubMed ID: 18432802
    [Abstract] [Full Text] [Related]

  • 52. Comparison of the cytostatic and cytolytic activity of tumor necrosis factor-alpha and interleukin 1 alpha in human malignant cell lines.
    Herzog TJ, Collin JL.
    Cytokine; 1992 May 28; 4(3):214-20. PubMed ID: 1498256
    [Abstract] [Full Text] [Related]

  • 53. The role of tumor necrosis factor receptors in tumor necrosis factor-alpha-mediated cytolysis of ovarian cancer cell lines.
    Kost ER, Herzog TJ, Adler LM, Williams S, Mutch DG.
    Am J Obstet Gynecol; 1996 Jan 28; 174(1 Pt 1):145-53. PubMed ID: 8571998
    [Abstract] [Full Text] [Related]

  • 54. Method for production of neuronal hybridoma using emetine and actinomycin D.
    Hikawa N, Takenaka T.
    Brain Res Brain Res Protoc; 1997 Aug 28; 1(3):224-6. PubMed ID: 9385057
    [Abstract] [Full Text] [Related]

  • 55. Effect of free fatty acids on the cytolytic activity of tumour necrosis factor/monocyte-derived cytotoxic factor.
    Bjerve KS, Espevik T, Kildahl-Andersen O, Nissen-Meyer J.
    Acta Pathol Microbiol Immunol Scand C; 1987 Feb 28; 95(1):21-6. PubMed ID: 3577767
    [Abstract] [Full Text] [Related]

  • 56. Inhibitors of protein and RNA synthesis block the cytotoxic effects of oxygenated sterols.
    Hwang PL.
    Biochim Biophys Acta; 1992 Jul 22; 1136(1):5-11. PubMed ID: 1379472
    [Abstract] [Full Text] [Related]

  • 57. Zn++ inhibits both tumor necrosis factor-mediated DNA fragmentation and cytolysis.
    Flieger D, Riethmüller G, Ziegler-Heitbrock HW.
    Int J Cancer; 1989 Aug 15; 44(2):315-9. PubMed ID: 2759737
    [Abstract] [Full Text] [Related]

  • 58. [Cardiotoxicity of emetine].
    Marino A, Costa R, De Natale G.
    Clin Ter; 1990 May 15; 133(3):131-43. PubMed ID: 2142900
    [Abstract] [Full Text] [Related]

  • 59. Role of oxidants in TNF-alpha-mediated cytotoxicity.
    O'Donnell VB, Azzi A.
    Biochem Soc Trans; 1995 May 15; 23(2):239S. PubMed ID: 7672259
    [No Abstract] [Full Text] [Related]

  • 60. Incompatibility of chemical protein synthesis inhibitors with accurate measurement of extended protein degradation rates.
    Chan C, Martin P, Liptrott NJ, Siccardi M, Almond L, Owen A.
    Pharmacol Res Perspect; 2017 Oct 15; 5(5):. PubMed ID: 28971619
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.